US7799793B2
Active / In Force
US
⏱️ 1.5 years remaining
N-alkylated rifampin
Assignee: Medtronic Inc
•
Filing: 2008-04-25
•
Granted: 2010-09-21
•
Expires: 2028-04-25
Abstract
Abstract Compounds of the formula: where X and Y are each independently H, halo, or C 1 -C 6 straight or branched chain substituted or unsubstituted alkyl.
Inventors
- 👤 William V. Ferris, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 01:26
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/02; C07D498/08; A; A61; A61P; A61P31/00; A61P31/04
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
44 words
A compound of the formula: or a pharmaceutically acceptable salt or isomer thereof, wherein X and Y are each independently H, halo, or C 1 -C 6 straight or branched chain unsubstituted alkyl, with the proviso that X and Y are not both H.
Claim 2
Dependent Claim
44 words
A compound of the formula: or a pharmaceutically acceptable salt or isomer thereof, wherein X and Y are each independently H, halo, or C 1 -C 6 straight or branched chain unsubstituted alkyl, with the proviso that X and Y are not both H.
Claim 3
Dependent Claim
27 words
A compound according to claim 1 , wherein wherein X and Y are each independently H or C 1 -C 3 straight or branched chain unsubstituted alkyl.
Claim 4
Dependent Claim
16 words
A pharmaceutical composition comprising: a compound according to claim 1 ; and a pharmaceutically acceptable carrier.
Claim 5
Dependent Claim
19 words
A method of inhibiting growth of bacteria, comprising: contacting the bacteria with a compound according to claim 1 .
Claim 6
Dependent Claim
26 words
A method for treating a bacterial infection in a patient, comprising: administering to the patient an effective amount of a compound according to claim 1 .
Claim 7
Dependent Claim
14 words
An isolated compound of the formula: or a pharmaceutically acceptable salt or isomer thereof.
Claim 8
Dependent Claim
14 words
An isolated compound of the formula: or a pharmaceutically acceptable salt or isomer thereof.
Claim 9
Dependent Claim
21 words
A pharmaceutical composition comprising: a compound of the formula: or a pharmaceutically salt or isomer thereof; and a pharmaceutically acceptable vehicle.
Claim 10
Dependent Claim
21 words
A pharmaceutical composition comprising: a compound of the formula: or a pharmaceutically salt or isomer thereof; and a pharmaceutically acceptable vehicle.
Claim 11
Dependent Claim
35 words
A method for treating a bacterial infection in a patient, comprising: administering to the patient a composition according to claim 7 , wherein the composition comprises an effective amount of the compound of Formula II.
Claim 12
Dependent Claim
35 words
A method for preventing a bacterial infection in a patient, comprising: administering to the patient a composition according to claim 7 , wherein the composition comprises an effective amount of the compound of Formula II.
References Cited (Backward Citations)
US4675180A
Cited
US4600518A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2013-09-20 | 2014-03-22 | 2014-09-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2017-09-20 | 2018-03-22 | 2018-09-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2021-09-20 | 2022-03-22 | 2022-09-21 | $7700.00 | Window Closed / Lapsed |